pneumococcal conjugate vaccine candidate
-
Pfizer announces positive top-Line results from Phase 3 study of 20-Valent pneumococcal conjugate vaccine in infants
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with US FDA Pfizer announced…
Read More »